Brinker Capital Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
FDCDDQ
CS
Brinker Capital Investments's PJP Position: Q1 2021 in Review
Brinker Capital Investments sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2021, closing a stake of 94,700 shares — an estimated $6.76M sold.
Brinker Capital Investments first reported a position in PJP in Q2 2013 and held it in 20 quarters. The position peaked at $23M in Q4 2019. 89 funds tracked by Wall St. Rank hold PJP as of Q1 2021.
- Brinker Capital Investments reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
- Brinker Capital Investments sold 94,700 Invesco Pharmaceuticals ETF shares in Q1 2021, an estimated $6.76M.
- Brinker Capital Investments first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 20 quarters.
- Brinker Capital Investments's Invesco Pharmaceuticals ETF position peaked at $23M in Q4 2019.
- 89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2021.
Based on Brinker Capital Investments's 13F filing for Q1 2021, filed 12 May 2021.